Editas Medicine (EDIT) Accumulated Depreciation & Amortization (2016 - 2025)
Historic Accumulated Depreciation & Amortization for Editas Medicine (EDIT) over the last 11 years, with Q3 2025 value amounting to $27.5 million.
- Editas Medicine's Accumulated Depreciation & Amortization fell 977.07% to $27.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.5 million, marking a year-over-year decrease of 977.07%. This contributed to the annual value of $31.6 million for FY2024, which is 2051.79% up from last year.
- As of Q3 2025, Editas Medicine's Accumulated Depreciation & Amortization stood at $27.5 million, which was down 977.07% from $26.8 million recorded in Q2 2025.
- Over the past 5 years, Editas Medicine's Accumulated Depreciation & Amortization peaked at $31.6 million during Q4 2024, and registered a low of $12.0 million during Q1 2021.
- Its 5-year average for Accumulated Depreciation & Amortization is $22.6 million, with a median of $23.5 million in 2023.
- Per our database at Business Quant, Editas Medicine's Accumulated Depreciation & Amortization soared by 4979.38% in 2021 and then plummeted by 977.07% in 2025.
- Over the past 5 years, Editas Medicine's Accumulated Depreciation & Amortization (Quarter) stood at $15.5 million in 2021, then soared by 38.81% to $21.5 million in 2022, then rose by 21.99% to $26.3 million in 2023, then grew by 20.52% to $31.6 million in 2024, then decreased by 12.96% to $27.5 million in 2025.
- Its Accumulated Depreciation & Amortization was $27.5 million in Q3 2025, compared to $26.8 million in Q2 2025 and $27.7 million in Q1 2025.